APH02174

N/A

Report date: 2025/10/29 17:33:29
NME

Base Information

Drug NameAPH02174
Drug Alias NameAPH-02174
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionInterleukin-1 receptor-associated kinase 4 degraders
TargetsInterleukin-1 receptor-associated kinase 4
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSun Yat-Sen UniversityYipinhong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSun Yat-Sen UniversityYipinhong Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A